Riskpilot← Back to searchSign inGet full accessENVAMED AB
ABActiveOrg 5568009137Skyttelinjen 88Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 20100 employees
Revenue 2025
SEK 310K
-60% vs 2024
EBITDA margin
10.9%
-94% vs 2024
Equity ratio
84.8%
Financial strength
Net profit 2025
SEK 371K
-53% vs 2024
| Revenue | SEK 310K | -60% |
| EBITDA | SEK 34K | -94% |
| Net profit | SEK 371K | -53% |
| Total assets | SEK 3,2M | +14% |
| Equity | SEK 2,7M | +6% |
| Employees | 0 | — |
Legal name
ENVAMED AB
Org number
5568009137
Legal form
Aktiebolag
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
17 februari 2010
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva läkarkonsultation inklusive bedömning av patientärenden, granskning av röntgendiagnostiska undersökningar, assistans vid operationer samt utföra andra läkaruppgifter inom hälsa och sjukvården. Dessutom ska bolaget bedriva författning och undervisning inom ramen för dessa områden.Ytterligare skall verksamheten bedriva konsultation och personlig instruktion för friskvård och personlig träning.
Address
Skyttelinjen 88
Email
timothyresch@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 111 | 233 | 207 | 780 | 310 |
| Staff expenses | — | — | — | −33 | −6 |
| EBITDA | 24 | 36 | −20 | 528 | 34 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 24 | 36 | −20 | 528 | 34 |
| Net financials | 381 | 489 | 701 | 373 | 568 |
| Profit before tax | 515 | 525 | 680 | 901 | 471 |
| Tax | −31 | −7 | — | −107 | −100 |
| Net profit | 484 | 518 | 680 | 793 | 371 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 317 | 1 612 | 2 140 | 2 836 | 3 233 |
| Equity | 1 171 | 1 502 | 1 995 | 2 584 | 2 740 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 65 | 30 | 64 | 172 | 282 |
| Total debt | 65 | 30 | 64 | 172 | 282 |
EBITDA margin
10.9%
This company
15.8%
Market median
-31% vs market
20212025
Equity ratio
84.8%
This company
38.2%
Market median
+122% vs market
20212025
Return on equity
13.5%
This company
18.4%
Market median
+27% vs market
20212025
Net profit margin
119.5%
This company
8.1%
Market median
+1375% vs market
20212025
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
20212025
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ENVAMED AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Timothy Andrew Resch | Chairman | 0 companies |
| Eva Annika Resch | Board of Directors | 0 companies |
| David Resch | Deputy Board Member | 0 companies |
| Christopher Sean Resch Thomason | Deputy Board Member | 0 companies |